Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
765 ARTÍCULOS , VIENDO DEL 16 AL 30
Improving Clinical Trials of Antioxidants in Alzheimer's Disease
Daly T.
J Alzheimers Dis. 2024;99(s1):S171-S181. doi: 10.3233/JAD-230308.
Microglia and Astrocytes in Alzheimer's Disease: Significance and Summary of Recent Advances
Deng Q, Wu C, Parker E, Liu TC, Duan R, Yang L.
Aging Dis. 2024 Aug 1;15(4):1537-1564. doi: 10.14336/AD.2023.0907.
Hakem FT, Fouad YF, Arafa RK.
Curr Top Med Chem. 2024;24(2):109-127. doi: 10.2174/0115680266259174231006070637.
Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach
Kumar S, Mahajan A, Ambatwar R, Khatik GL.
Curr Med Chem. 2024;31(37):6032-6062. doi: 10.2174/0109298673264076230921065945.
Potential Neuroprotective Strategies using Smart Drug Delivery Systems for Alzheimer's Disease
Khan J, Yadav S, Alam MA.
Infect Disord Drug Targets. 2024;24(3):e231023222565. doi: 10.2174/0118715265254985231012065058.
γ-Secretase: once and future drug target for Alzheimer's disease
Wolfe MS.
Expert Opin Drug Discov. 2024 Jan-Jun;19(1):5-8. doi: 10.1080/17460441.2023.2277350. Epub 2024 Jan 8.
Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease
Li L, Wang F, Jia X, Yao L, Liu Y.
Mini Rev Med Chem. 2024;24(17):1590-1601. doi: 10.2174/0113895575263783231009051957.
Transdermal Therapeutic Systems for the Treatment of Alzheimer's Disease: A Patent Review
Basso L, Fagundes SC, Staudt T, da Rosa K, Langaro E, Omidian H, Bertol CD.
CNS Neurol Disord Drug Targets. 2024;23(9):1075-1084. doi: 10.2174/0118715273275957231102044934.
Alzheimer's Disease and Cancer: Common Targets
Yang X, Dai J, Wu C, Liu Z.
Mini Rev Med Chem. 2024;24(10):983-1000. doi: 10.2174/0113895575263108231031132404.
Huang P, Lin L, Zhang J, Cheng Y, Pan X.
Expert Rev Neurother. 2024 Jan-Jun;24(1):117-127. doi: 10.1080/14737175.2023.2293225. Epub 2024 Jan 8.
Sulfopropanoic acid derivatives for treating neurodegenerative disorders: a patent spotlight
Al-Horani RA.
Pharm Pat Anal. 2024;13(4-6):131-137. doi: 10.1080/20468954.2024.2363657. Epub 2024 Jun 20.
Oxidative stress in Alzheimer's disease: current knowledge of signaling pathways and therapeutics
Dhapola R, Beura SK, Sharma P, Singh SK, HariKrishnaReddy D.
Mol Biol Rep. 2024 Jan 2;51(1):48. doi: 10.1007/s11033-023-09021-z.
Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies
Seo DO, Holtzman DM.
Exp Mol Med. 2024 Feb;56(1):86-94. doi: 10.1038/s12276-023-01146-2. Epub 2024 Jan 4.
Therapeutic Effects of the major alkaloid constituents of Evodia rutaecarpa in Alzheimer's disease
Cao Q, Dong P, Han H.
Psychogeriatrics. 2024 Mar;24(2):443-457. doi: 10.1111/psyg.13051. Epub 2024 Jan 3.
Radiotherapy for non-cancer diseases: benefits and long-term risks
Thariat J, Little MP, Zablotska LB, Samson P, O'Banion MK, Leuraud K, Bergom C, Girault G, Azimzadeh O, Bouffler S, Hamada N.
Int J Radiat Biol. 2024;100(4):505-526. doi: 10.1080/09553002.2023.2295966. Epub 2024 Jan 5.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.